Shopping Cart
- Remove All
- Your shopping cart is currently empty
ACY-957 (HDAC Inhibitor C001) is an orally active and selective inhibitor of HDAC1 and HDAC2 (IC50s: 7 nM, 18 nM, and 1300 nM against HDAC1/2/3) and shows no inhibition on HDAC4/5/6/7/8/9.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $97 | In Stock | |
2 mg | $146 | In Stock | |
5 mg | $255 | In Stock | |
10 mg | $313 | In Stock | |
25 mg | $479 | In Stock | |
50 mg | $679 | In Stock | |
100 mg | $892 | In Stock | |
1 mL x 10 mM (in DMSO) | $279 | In Stock |
Description | ACY-957 (HDAC Inhibitor C001) is an orally active and selective inhibitor of HDAC1 and HDAC2 (IC50s: 7 nM, 18 nM, and 1300 nM against HDAC1/2/3) and shows no inhibition on HDAC4/5/6/7/8/9. |
Targets&IC50 | HDAC2:18 nM, HDAC3:1300 nM, HDAC1:7 nM |
In vitro | ACY-957 is a selective inhibitor of HDAC1 and HDAC2, with IC50 values of 7 nM for HDAC1, 18 nM for HDAC2, and 1300 nM for HDAC3, showing no inhibition of HDAC4/5/6/7/8/9. It exhibits an IC50 of 304 nM for HDAC2 in primary hematopoietic progenitors [1]. |
Alias | HDAC Inhibitor C001 |
Molecular Weight | 429.54 |
Formula | C24H23N5OS |
Cas No. | 1609389-52-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (116.4 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.